Drug Interaction Study

Clinical trial NCT06194864 · COMPLETED

Trial details

NCT number: NCT06194864
Sponsor: Emalex Biosciences Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Drug Interaction

Start date: 2024-01-18
Primary completion: 2024-05-14
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.